Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Lichen Sclerosus and Vulval Health (ILSVH) is a specialized non-profit research organization dedicated to advancing the clinical understanding and treatment of Lichen Sclerosus and related vulval disorders. The institute focuses on conducting high-quality clinical trials to evaluate both traditional pharmacological interventions and emerging regenerative therapies, such as platelet-rich plasma and autologous fat grafting. Beyond research, ILSVH provides critical education for healthcare professionals and patients to improve diagnostic accuracy and care standards for these often-neglected conditions. By bridging the gap between clinical practice and academic research, the institute aims to establish evidence-based protocols that enhance the quality of life for patients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Lichen Sclerosus and Vulval Health.